Drugs / 011516X
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04393441 | Jun 2020 → Jun 2021 | dry eye syndrome | Allergan | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 011516X | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04393441 ↗ |
| Route | Topical | “Topical eye drops” NCT04393441 ↗ |